Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (1459)	3/19/1998 8:56:00 AM
From: John M. Butler	Read Replies (1) \| Respond to of 5736

Jane's reiteration of the purpose of MONITORING for increased bilirubin levels is vitally important. My middle child did not start developing hyperbilirubinemia until the day AFTER her birth. The heel stick done on day one was OK, and in normal deliveries, my daughter would have gone home on day two and ended up back at the hospital when she started turning yellow. As it was, she was a C-section baby and the nurse noticed the change in pigmentation during the night of her 2nd day of life. A Colormate III reading at day one, plus an additional reading at discharge time would have picked up the change in pigmentation even if she had been going home on day 2, though the color change may not have been readily distinguishable with the naked eye. Do doctors want to do WHATEVER they can to prevent addition sticks of a baby? You bet they do ! When looking at the overall cost of having a baby in the hospital these days, a $20 test that will avoid dealing with drawing blood is an insignificant amount. But when multiplied by MILLIONS of tests, it becomes VERY significant to the CCSI stockholders! JB